Home » Newsletters » BioWorld Science

BioWorld Science

April 12, 2016

View Archived Issues

Mymetics' HIV vaccine candidate shows promise in preclinical study

Ipsen describes novel melanocortin MC2 receptor antagonist for Cushing's disease

FDA grants fast track status for Carbavance

Immunogenicity and safety of MG-1109

Ariad initiates phase III trial of brigatinib in patients with ALK-positive NSCLC

Data reported from phase III study of surotomycin for CDAD

Altor BioScience and NCI partner to develop cancer immunotherapeutics

Encouraging results seen in phase II murepavadin study

Celgene exercises option to develop and commercialize Juno's CD19-directed drug candidates

Bayer Schering Pharma patents coagulation factor XIa and KLKB1 inhibitors

Araxes Pharma discloses RAS inhibitors

Gilead Sciences describes TBK1 and IKK-epsilon inhibitors

BTA-585 enters phase IIa trial for the treatment of RSV infections

Tetra Discovery Partners reports PDE4 inhibitors

Hydra Biosciences presents TRPA1 antagonists

GW Pharmaceuticals initiates phase III pivotal trial of Epidiolex in tuberous sclerosis complex

RedHill Biopharma starts phase II trial of Bekinda in patients with IBS-D

Enrollment open in phase I study of MIW-815 for advanced cancers

Hutchison MediPharma initiates first-in-human study of HMPL-689

Regeneron and Intellia sign CRISPR/Cas-based licensing and collaboration agreement

Cerecor awarded NIDA grant

Cardiac peptide proANP(31-67) beneficial in patients with congestive heart failure

Nordic Nanovector and PSI enter R&D agreement

FDA grants accelerated approval to Venclexta for relapsed/refractory CLL with 17p deletion

HalioDx and NanoString Technologies collaborate on gene expression assays in immuno-oncology

Molecular Stethoscope collaborates with academic and medical institutions on diagnostic development

Cancer metabolic imaging trial begins in U.K.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...